Evidence map›Paper›PMID 30842597›Full record

ArticleJournal of human genetics2019

Previously undescribed thyroid-specific miRNA sequences in papillary thyroid carcinoma.

Mateus Camargo Barros-Filho, Michelle Pewarchuk, Brenda de Carvalho Minatel, Adam P Sage, Erin A Marshall, Victor D Martinez, Leigha D Rock, Gavin MacAulay, Luiz Paulo Kowalski, Silvia Regina Rogatto and 2 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Mateus Camargo Barros-FilhoDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada. mbarros@bccrc.ca.
Michelle PewarchukDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Brenda de Carvalho MinatelDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Adam P SageDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Erin A MarshallDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Victor D MartinezDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Leigha D RockDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.ORCID http://orcid.org/0000-0002-7258-3837
Gavin MacAulayDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Luiz Paulo KowalskiInternational Research Center, A.C.Camargo Cancer Center, Sao Paulo, Brazil.
Silvia Regina RogattoVejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Cathie GarnisDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Wan L LamDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Occupational Cancer Research Centre · CAAC Camargo Hospital · BRUniversity of British Columbia · CAUniversity of Southern Denmark · DK

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2015/17707-5Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2015/20748-5Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2018/06138-8Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) FDN-143345
6 · The paper itself

Abstract

Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy, wherein diagnostic limitations and lack of accurate prognostic factors are important clinical challenges. In this study, we report the discovery of 234 novel miRNAs in non-neoplastic thyroid and PTC samples, obtained from publicly available small RNA sequencing datasets (TCGA and GEO). These sequences were observed to display similar molecular features compared to currently annotated miRNAs. These potentially novel miRNAs presented tissue-specificity and largely decreased expression in PTC compared to non-neoplastic samples. We showed that the disrupted novel miRNAs have diagnostic and prognostic potential, and were associated with BRAF mutation, a frequent alteration related to more aggressive PTC. In conclusion, our results expand the miRNA repertoire in thyroid tissues and highlight the potential biological role and clinical utility of previously unannotated miRNAs.

Indexed as

MicroRNAsRNA, NeoplasmThyroid Cancer, PapillaryThyroid NeoplasmsFemaleHumansMaleMolecular Sequence AnnotationMutationProto-Oncogene Proteins B-rafBRAF protein, humanMicroRNAsProto-Oncogene Proteins B-rafRNA, Neoplasm

Identifiers

PMID30842597
OpenAlexW2920311696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.